1LIN
CALMODULIN COMPLEXED WITH TRIFLUOPERAZINE (1:4 COMPLEX)
Summary for 1LIN
Entry DOI | 10.2210/pdb1lin/pdb |
Descriptor | CALMODULIN, CALCIUM ION, 10-[3-(4-METHYL-PIPERAZIN-1-YL)-PROPYL]-2-TRIFLUOROMETHYL-10H-PHENOTHIAZINE, ... (4 entities in total) |
Functional Keywords | calcium-binding protein |
Biological source | Bos taurus (cattle) |
Cellular location | Cytoplasm: P62157 |
Total number of polymer chains | 1 |
Total formula weight | 18511.65 |
Authors | Vandonselaar, M.,Hickie, R.A.,Quail, J.W.,Delbaere, L.T.J. (deposition date: 1995-10-11, release date: 1996-03-08, Last modification date: 2024-02-14) |
Primary citation | Vandonselaar, M.,Hickie, R.A.,Quail, J.W.,Delbaere, L.T. Trifluoperazine-induced conformational change in Ca(2+)-calmodulin. Nat.Struct.Biol., 1:795-801, 1994 Cited by PubMed Abstract: Here we show that, as a consequence of binding the drug trifluoperazine, a major conformational movement occurs in Ca(2+)-calmodulin (CaM). The tertiary structure changes from an elongated dumb-bell, with exposed hydrophobic surfaces, to a compact globular form which can no longer interact with its target enzymes. It is likely that inactivation of Ca(2+)-CaM by trifluoperazine is due to this major tertiary-structural alteration in Ca(2+)-CaM, which is initiated and stabilized by drug binding. This conformational change is similar to that which occurs on the binding of Ca(2+)-CaM to target peptides. Two hydrophobic binding pockets, created by amino acid residues adjacent to Ca(2+)-coordinating residues, form the key recognition sites on Ca(2+)-CaM for both inhibitors and target enzymes. PubMed: 7634090DOI: 10.1038/nsb1194-795 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2 Å) |
Structure validation
Download full validation report